Literature DB >> 8561867

Matrilysin expression in human prostate carcinoma.

J D Knox1, C Wolf, K McDaniel, V Clark, M Loriot, G T Bowden, R B Nagle.   

Abstract

The metalloproteinases, a multigene family of metal-requiring enzymes, have been suggested to play a role in tumor invasion and metastasis. Previously, we demonstrated that human primary prostate tumors express higher levels of matrilysin and gelatinase A mRNA than normal prostate does. In the study presented here, we used in situ hybridization and immunohistochemical staining of serial sections of paraffin-embedded primary prostate tumors to compare the sites of matrilysin and gelatinase A expression and protein localization. These results confirmed the epithelial nature of matrilysin expression and protein localization. In contrast, gelatinase A mRNA was localized to the interstitial stroma, whereas the protein was associated with the epithelial tumor cells. In situ hybridization was also used to demonstrate that gelatinase B expression was restricted to macrophages infiltrating the tumors. Proteins isolated from an additional set of frozen tumor specimens were analyzed by western blotting to determine the relative amounts of matrilysin in the active and proenzyme forms. The western analyses demonstrated that in all cases in which matrilysin was detected, at least some of the enzyme was in the active form. These results are discussed with respect to the possible role these enzymes may play in prostate tumor progression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8561867     DOI: 10.1002/(SICI)1098-2744(199601)15:1<57::AID-MC8>3.0.CO;2-P

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  16 in total

1.  Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.

Authors:  Laurie E Littlepage; Mark D Sternlicht; Nathalie Rougier; Joanna Phillips; Eugenio Gallo; Ying Yu; Kurt Williams; Audrey Brenot; Jeffrey I Gordon; Zena Werb
Journal:  Cancer Res       Date:  2010-03-09       Impact factor: 12.701

2.  Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.

Authors:  D C von Bredow; A E Cress; E W Howard; G T Bowden; R B Nagle
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

3.  Fibroblast growth factor-1 induced promatrilysin expression through the activation of extracellular-regulated kinases and STAT3.

Authors:  Thirupandiyur S Udayakumar; Mimi Suzanne Stratton; Raymond B Nagle; George Timothy Bowden
Journal:  Neoplasia       Date:  2002 Jan-Feb       Impact factor: 5.715

4.  The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer.

Authors:  Jerry J Jaboin; Misun Hwang; Zachary Lopater; Heidi Chen; Geoffrey L Ray; Carmen Perez; Qiuyin Cai; Marcia L Wills; Bo Lu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-03       Impact factor: 7.038

5.  Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis.

Authors:  B Fingleton; T Vargo-Gogola; H C Crawford; L M Matrisian
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

6.  Interleukin-1beta-induced promatrilysin expression is mediated by NFkappaB-regulated synthesis of interleukin-6 in the prostate carcinoma cell line, LNCaP.

Authors:  M S Maliner-Stratton; R D Klein; T S Udayakumar; R B Nagle; G T Bowden
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

7.  Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma.

Authors:  T L Davis; A E Cress; B L Dalkin; R B Nagle
Journal:  Prostate       Date:  2001-02-15       Impact factor: 4.104

8.  Immunohistochemical expression of matrix metalloproteinase-9 and inhibitor of matrix metalloproteinase-1 in prostate adenocarcinoma.

Authors:  Igor I Babichenko; Mikhail I Andriukhin; Sergey Pulbere; Artem Loktev
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

9.  Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity.

Authors:  H Kataoka; H Uchino; T Iwamura; M Seiki; K Nabeshima; M Koono
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

10.  Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer.

Authors:  A Senota; F Itoh; H Yamamoto; Y Adachi; Y Hinoda; K Imai
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.